
Mill Creek Life Sciences develops and commercializes cell culture supplements and technologies for cellular therapeutics and research.
Mill Creek Life Sciences, founded to advance cellular and biologic therapeutics, focuses on developing and commercializing cell culture supplements and technologies. Their core mission is to accelerate cell-based therapies for patients by providing high-quality tools and intellectual property for clinical and research markets. The company’s flagship products, PLTMax® and PLTGold®, are human platelet lysates designed to enhance the growth of stem cells and primary cells.
Notable affiliated individuals include experts in cellular therapeutics and biologics. Mill Creek Life Sciences has achieved significant milestones, including the widespread use of their products in growing cells for thousands of patients globally. Their impact is evident in the acceleration of cell-based therapies, contributing to advancements in medical research and treatment options.

Stemedica Cell Technologies
stemedica.com

Platelet BioGenesis

Celularity
celularity.com

Castle Creek Biosciences

Cellara

Cellular Engineering Technologies
celleng-tech.com

Trailhead Biosystems

Xcell Biosciences
xcellbio.com

BioLife Solutions
MultiCell Technologies

PurCell Bio
purcell-bio.com

RoosterBio

Progenitor Life Sciences

Cellebration Life Sciences

MitoStem
Companies similar to Mill Creek Life Sciences include Stemedica Cell Technologies, Platelet BioGenesis, Celularity and Castle Creek Biosciences.
Mill Creek Life Sciences was founded in 2010.
Mill Creek Life Sciences' headquarters is located in Rochester, MN, US.
Mill Creek Life Sciences' most recent funding round was for $100k (USD) in June 2019.
As of Jun 18, 2019, Mill Creek Life Sciences has raised a total of $825k (USD).
Mill Creek Life Sciences has 8 employees as of Feb 5, 2024.